SCHEMBL8527561

SCHEMBL8527561

CCCc1cc2cc[nH]c2cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 1/20 0.51
AHR P35869 6/20 0.43
NR4A2 P43354 5/20 0.43
CMA1 P23946 1/20 0.43
F7 P08709 1/20 0.43
LTA4H P09960 1/20 0.43
F3 P13726 1/20 0.43
GPR84 Q9NQS5 1/20 0.40
CYP2D6 P10635 2/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8526792 0.86 CSNK2A1 (0.55) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL31201815 0.84 CSNK2A1 (0.53) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL14722496 0.79 CSNK2A1 (0.55) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL9004441 0.79 CSNK2A1 (0.50) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL613747 0.75 CSNK2A1 (0.69) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL10289632 0.74 GPR84 (0.48) CSNK2A1AHRNR4A2CMA1F7
Tert-Butyl Formate SCHEMBL27779443 0.72 CSNK2A1 (0.41) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL615624 0.72 CSNK2A1 (0.60) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL27447560 0.71 CSNK2A1 (0.50) CSNK2A1AHRNR4A2CMA1F7
SCHEMBL8526222 0.71 CSNK2A1 (0.55) CSNK2A1AHRNR4A2CMA1F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5834494-A SEROTONIN 5HT2B/2C RECEPTOR ANTAGONISTS; CNS NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDERS; IRRITABLE BOWEL SYNDROME SMITHKLINE BEECHAM P.L.C. (GB) 1998-11-10 US disclosed
EP-0707581-B1 INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1997-02-26 EP disclosed
CN-1129937-A Indoline derivatives as 5HT2C antagonists SMITHKLINE BEECHAM PLC (GB) 1996-08-28 CN disclosed
EP-0707581-A1 INDOLINE DERIVATIVES AS 5HT 2C? ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-04-24 EP disclosed
WO-1995001976-A1 INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-01-19 WO disclosed